ConductScience.org, home

Trial · NCT02010151

Dispatcher-Activated Neighborhood Access Defibrillation and Cardiopulmonary Resuscitation

NCT02010151, Not applicable, Completed, Seoul National University Hospital; results first posted 2020-03-30

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Dispatcher-Activated Neighborhood Access Defibrillation and Cardiopulmonary Resuscitation. Trials, record NCT02010151. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02010151

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Dispatcher-Activated Neighborhood Access Defibrillation and Cardiopulmonary Resuscitation
NCT number
NCT02010151
Status
Completed
Phases
Not applicable
Enrollment
3,194 participants, actual
Lead sponsor
Seoul National University Hospital
Conditions
Out of Hospital Cardiac Arrest
Interventions
NAD-CPR
First posted
2013-12-12
Last updated
2020-03-30
Results first posted
2020-03-30
Limitations and caveats
It's not randomized trial, it's before-after study.

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumber of Participants Surviving at Hospital Dischargedischarge time from first admission from emergency department within 2 monthwe compared the survival to discharge rate between before intervention period and intervention period. Survival to discharge checked at the discharge point of hospital.
SecondaryNumber of Participants With Pre-Hospital Return of Spontaneous Circulation (ROSC)hospital arriving time from ambulance within 2 hourswe compared the Pre-hospital return of spontaneous circulation (ROSC) rate between before intervention period and intervention period.
SecondaryNumber of Participants With Good Neurological Recoverydischarge time from first admission from emergency department within 2 monthCerebral performance category 1 or 2 is defined as good neurological recovery. we compared the good neurological recovery rate between before intervention period and intervention period.

Outcomes3

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Participants Surviving at Hospital Dischargedischarge time from first admission from emergency department within 2 monthStudy population excluding exclusion criteriaParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With Pre-Hospital Return of Spontaneous Circulation (ROSC)hospital arriving time from ambulance within 2 hoursParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With Good Neurological Recoverydischarge time from first admission from emergency department within 2 monthParticipantsCOUNT_OF_PARTICIPANTS

Results by group6

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Participants Surviving at Hospital DischargeConventional Dispatcher CPR135Participants
Number of Participants Surviving at Hospital DischargeNAD-CPR216Participants
Number of Participants With Pre-Hospital Return of Spontaneous Circulation (ROSC)Conventional Dispatcher CPR107Participants
Number of Participants With Pre-Hospital Return of Spontaneous Circulation (ROSC)NAD-CPR223Participants
Number of Participants With Good Neurological RecoveryConventional Dispatcher CPR68Participants
Number of Participants With Good Neurological RecoveryNAD-CPR140Participants

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDConventional Dispatcher Assisted CPR1,498
Overall StudySTARTEDNAD-CPR1,696
Overall StudyCOMPLETEDConventional Dispatcher Assisted CPR1,498
Overall StudyCOMPLETEDNAD-CPR1,696
Overall StudyNOT COMPLETEDConventional Dispatcher Assisted CPR0
Overall StudyNOT COMPLETEDNAD-CPR0

Adverse events2

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
seriousdeathCardiac disordersConventional Dispatcher CPR1,3631,4981,363
seriousdeathCardiac disordersNAD-CPR1,4801,6961,480

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityConventional Dispatcher CPR1,3631,498
Total, all-cause mortalityNAD-CPR1,4801,696
Total, other adverse eventsConventional Dispatcher CPR01,498
Total, other adverse eventsNAD-CPR01,696
Total, serious adverse eventsConventional Dispatcher CPR1,3631,498
Total, serious adverse eventsNAD-CPR1,4801,696

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
30902689DERIVED

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons5

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Conventional Dispatcher CPR vs NAD-CPR: Number of Participants With Pre-Hospital Return of Spontaneous Circulation (ROSC)Trial comparisons
Conventional Dispatcher CPR vs NAD-CPR: deaths from any causeTrial comparisons
Conventional Dispatcher CPR vs NAD-CPR: Number of Participants With Good Neurological RecoveryTrial comparisons
Conventional Dispatcher CPR vs NAD-CPR: Number of Participants Surviving at Hospital DischargeTrial comparisons
Conventional Dispatcher CPR vs NAD-CPR: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02010151

GET https://conductscience.org/api/trials/v1/NCT02010151/registered